Schneider David F, Nookala Ratnam, Jaraczewski Taylor J, Chen Herbert, Solorzano Carmen C, Sippel Rebecca S
Department of Surgery, University of Wisconsin, Madison, WI, USA,
Ann Surg Oncol. 2014 Jul;21(7):2303-9. doi: 10.1245/s10434-014-3542-8. Epub 2014 Feb 13.
The purpose of this study was to determine how the timing of thyroidectomy influenced postoperative weight change.
We conducted a two-institution study, identifying patients treated with total thyroidectomy for hyperthyroidism. Patients were classified as 'early' if they were referred for surgery as the first treatment option, or 'delayed' if they were previously treated with radioactive iodine (RAI). Groups were compared with the Student's t-test or χ (2) test where appropriate.
There were 204 patients undergoing thyroidectomy for hyperthyroidism. Of these, 171 patients were classified as early and 33 were classified as delayed. Overall, patients gained 6.0 % ± 0.8 of their preoperative body weight at last follow-up. Preoperative body mass indexes (BMIs) were similar between groups (p = 0.98), and the median follow-up time was 388 days (range 15-1,584 days). Both groups gained weight until they achieved a normal thyroid-stimulating hormone (TSH) postoperatively. After achieving a normal TSH, the early group stabilized or lost weight (-0.2 lbs/day), while the delayed group continued to gain weight (0.02 lbs/day; p = 0.61). At last follow-up, there were significantly more patients in the delayed group who increased their BMI category compared with the early group (42.4 vs. 21.6 %; p = 0.01). Twice as many patients in the delayed group moved up or into an unhealthy BMI category (overweight or obese) compared with the early group (39.4 vs. 19.3 %; p = 0.01).
Compared with patients initially treated with RAI, patients with hyperthyroidism who underwent surgery as the first treatment were less likely to become overweight or obese postoperatively.
本研究旨在确定甲状腺切除术的时机如何影响术后体重变化。
我们进行了一项双机构研究,确定接受甲状腺全切除术治疗甲亢的患者。如果患者作为首选治疗方案被转诊进行手术,则分类为“早期”;如果患者先前接受过放射性碘(RAI)治疗,则分类为“延迟”。在适当情况下,使用学生t检验或χ²检验对组间进行比较。
有204例患者因甲亢接受甲状腺切除术。其中,171例患者分类为早期,33例分类为延迟。总体而言,在最后一次随访时,患者体重比术前增加了±0.8%。术前两组的体重指数(BMI)相似(p = 0.98),中位随访时间为388天(范围15 - 1584天)。两组患者在术后促甲状腺激素(TSH)恢复正常之前均体重增加。在TSH恢复正常后,早期组体重稳定或减轻(-0.2磅/天),而延迟组继续体重增加(0.02磅/天;p = 0.61)。在最后一次随访时,与早期组相比,延迟组中BMI类别增加的患者明显更多(42.4%对21.6%;p = 0.01)。与早期组相比,延迟组中体重上升或进入不健康BMI类别(超重或肥胖)的患者是其两倍(39.4%对19.3%;p = 0.01)。
与最初接受RAI治疗的患者相比,作为首选治疗接受手术的甲亢患者术后超重或肥胖的可能性较小。